Developing nanotherapies for neurodegenerative diseases: ORMOSIL and its potential in axonal transport

2012 ◽  
Vol 3 (10) ◽  
pp. 1189-1198 ◽  
Author(s):  
Shermali Gunawardena
2000 ◽  
Vol 150 (1) ◽  
pp. 165-176 ◽  
Author(s):  
Steven Ackerley ◽  
Andrew J. Grierson ◽  
Janet Brownlees ◽  
Paul Thornhill ◽  
Brian H. Anderton ◽  
...  

Neurofilaments are transported through axons by slow axonal transport. Abnormal accumulations of neurofilaments are seen in several neurodegenerative diseases, and this suggests that neurofilament transport is defective. Excitotoxic mechanisms involving glutamate are believed to be part of the pathogenic process in some neurodegenerative diseases, but there is currently little evidence to link glutamate with neurofilament transport. We have used a novel technique involving transfection of the green fluorescent protein–tagged neurofilament middle chain to measure neurofilament transport in cultured neurons. Treatment of the cells with glutamate induces a slowing of neurofilament transport. Phosphorylation of the side-arm domains of neurofilaments has been associated with a slowing of neurofilament transport, and we show that glutamate causes increased phosphorylation of these domains in cell bodies. We also show that glutamate activates members of the mitogen-activated protein kinase family, and that these kinases will phosphorylate neurofilament side-arm domains. These results provide a molecular framework to link glutamate excitotoxicity with neurofilament accumulation seen in some neurodegenerative diseases.


2009 ◽  
pp. 1199-1203 ◽  
Author(s):  
S. Roy ◽  
V.M.-Y. Lee ◽  
J.Q. Trojanowski

PLoS ONE ◽  
2014 ◽  
Vol 9 (8) ◽  
pp. e104617 ◽  
Author(s):  
Min Jung Kang ◽  
Timothy J. Hansen ◽  
Monique Mickiewicz ◽  
Tadeusz J. Kaczynski ◽  
Samantha Fye ◽  
...  

2009 ◽  
Vol 29 (41) ◽  
pp. 12776-12786 ◽  
Author(s):  
G. A. Morfini ◽  
M. Burns ◽  
L. I. Binder ◽  
N. M. Kanaan ◽  
N. LaPointe ◽  
...  

2018 ◽  
Vol 1693 ◽  
pp. 75-91 ◽  
Author(s):  
Bilal Khalil ◽  
Dmytro Morderer ◽  
Phillip L. Price ◽  
Feilin Liu ◽  
Wilfried Rossoll

2021 ◽  
Author(s):  
Christopher L. Berger ◽  
Dominique V. Lessard

Many neurodegenerative diseases result from dysfunction of axonal transport, a highly regulated cellular process responsible for site-specific neuronal cargo delivery. The kinesin-3 family member KIF1A is a key mediator of this process by facilitating long-distance cargo delivery in a spatiotemporally regulated manner. While misregulation of KIF1A cargo delivery is observed in many neurodegenerative diseases, the regulatory mechanisms responsible for KIF1A cargo transport are largely unexplored. Our lab has recently characterized a mechanism for a unique pausing behavior of KIF1A in between processive segments on the microtubule. This behavior, mediated through an interaction between the KIF1A K-loop and the polyglutamylated C-terminal tails of tubulin, helps us further understand how KIF1A conducts long-range cargo transport. However, how this pausing behavior is influenced by other regulatory factors on the microtubule is an unexplored concept. The microtubule associated protein Tau is one potential regulator, as altered Tau function is a pathological marker in many neurodegenerative diseases. However, while the effect of Tau on kinesin-1 and -2 has been extensively characterized, its role in regulating KIF1A transport is greatly unexplored at the behavioral level. Using single-molecule imaging, we have identified Tau-mediated regulation of KIF1A pausing behavior and motility. Specifically, our findings imply a competitive interaction between Tau and KIF1A for the C-terminal tails of tubulin. We introduce a new mechanism of Tau-mediated kinesin regulation by inhibiting the ability of KIF1A to use C-terminal tail reliant pauses to connect multiple processive segments into a longer run length. Moreover, we have correlated this regulatory mechanism to the behavioral dynamics of Tau, further elucidating the function of Tau diffusive and static behavioral state on the microtubule surface. In summary, we introduce a new mechanism of Tau-mediated motility regulation, providing insight on how disruptions in axonal transport can lead to disease state pathology.


Author(s):  
Andrey V. Kuznetsov

This paper simulates effects of structural changes in the microtubule (MT) system on mass transfer in an axon. Understanding this process is important for understanding the underlying reasons for many neurodegenerative diseases, such as Alzheimer’s disease. In particular, it is investigated how the degree of polar mismatching in an MT swirl affects organelle trap regions in the axon and inhibiting transport of organelles down the axon. The model is based on modified Smith-Simmons equations governing molecular-motor-assisted transport in neurons. It is established that the structure that develops as a result of a region with disoriented MTs (the MT swirl) consists of two organelle traps, the trap to the left of the swirl region accumulates plus-end oriented organelles and the trap to the right of this region accumulates minus-end oriented organelles. The presence of such a structure is shown to decrease the transport of organelles toward the synapse of the axon. Four cases with a different degree of polar mismatching in the swirl region are investigated; the results are compared with simulations for a healthy axon, in which case organelle traps are absent.


Sign in / Sign up

Export Citation Format

Share Document